Otsuka Holdings
4578.T
#799
Rank
A$45.47 B
Marketcap
A$86.10
Share price
-1.25%
Change (1 day)
1.63%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: A$1.57 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are A$14.47 Billion. In 2023 the company made an earning of A$1.57 Billion a decrease over its 2022 earnings that were of A$1.98 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023A$1.57 B-20.93%
2022A$1.98 B-12.7%
2021A$2.27 B-19.92%
2020A$2.84 B13.9%
2019A$2.49 B52.07%
2018A$1.64 B11.22%
2017A$1.47 B-36.03%
2016A$2.30 B31.15%
2015A$1.75 B
2013A$3.65 B33.52%
2012A$2.73 B-4.65%
2011A$2.86 B45.53%
2010A$1.97 B